Table 3. Percentage of patients who developed worse cardiac remodeling according to the catestatin concentrations at D3.
| Parameters | Low catestatin (<28.71 ng/ml) | High catestatin (>28.71 ng/ml) | p value |
|---|---|---|---|
| LVEDD, n (%) | 2 (5.6) | 21 (58.3) | <0.0001 |
| EF, n (%) | 1 (2.8) | 15 (41.7) | <0.0001 |
| IVS, n (%) | 2 (5.6) | 1 (2.8) | 0.5553 |
| LVPW, n (%) | 1 (2.8) | 1 (2.8) | 1.0000 |
| E, n (%) | 0 (0.0) | 6 (16.7) | 0.0105 |
| A, n (%) | 14 (38.9) | 20 (55.6) | 0.1567 |
| E’, n (%) | 1 (2.8) | 12 (33.3) | 0.0007 |
| E/A, n (%) | 2 (5.6) | 17 (47.2) | <0.0001 |
| E/E’, n (%) | 7 (19.4) | 26 (72.2) | <0.0001 |
LVEDD, left ventricular end-diastolic dimension; EF, ejection fraction; IVS, Interventricular septal end diastolic dimension; LVPW, left ventricular posterior wall thickness; E, peak early diastolic mitral flow velocity; A, peak late diastolic mitral flow velocity; E’, doppler-derived peak early diastolic mitral flow velocity.
The following conditions were considered to be worse: increased LVEDD; decreased EF; increased IVS; increased LPVW; decreased E; increased A; decreased E’; decreased E/A; or increased E/E’.